Metrics as of 10/17/2026, 05:27 AM (Berlin time), refresh in progress.
DocCheck Stock
DocCheck AG
Company data
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Country
- Germany
- CEO
- Frank Nicolas Antwerpes
- Employees
- 414
- Market cap
- €52 M
- IPO
- 30/01/2012
DocCheck AG is a healthcare company based in Cologne, Germany. Founded in 1990, the company offers community, agency, and e-commerce services for the European healthcare sector. Its business model includes developing and implementing communication strategies for media within the healthcare and business-to-business…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
DocCheck stock: price history
1D
-1.9%
1W
-2.9%
1M
-9.7%
6M
-19.0%
YTD
-17.1%
1Y
-22.1%
2Y
+18.6%
5Y
-59.2%
10Y
+40.5%
Next earnings date
Next earnings date
No date known
Volatility around earnings
~12% weaker price swings than usual
Ask the agents about DocCheck
DocCheck stock metrics
P/E
11.09
P/B
1.35
EV/EBITDA
4.25
RETURN ON EQUITY
4.7%
NET MARGIN
6.4%
DEBT/EQUITY
0.07
DIVIDEND YIELD
9.8%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
20.3%
FLOAT SHARES
1,031,000
AVG. DAILY VOLUME (30D)
431
Dividends
Comparable stocks
Frequently asked questions about DocCheck stock
What does DocCheck do?
DocCheck AG is a company in the Healthcare sector, Medical - Distribution industry, headquartered in Germany.
The CEO is Frank Nicolas Antwerpes, the company employs around 414 people.
The IPO was on 30/01/2012; the stock trades on XETRA under the ticker AJ91.DE.
When does DocCheck report next?
Around past earnings, price swings were roughly -12% stronger than usual.
Does DocCheck pay a dividend?
Yes. The last dividend was €1.00 per share, ex-date 29/05/2026, paid on 02/06/2026.
The dividend yield is 9.8% (as of 30/06/2026).
Which stocks are comparable to DocCheck?
Comparable stocks include McKesson, Cencora, Cardinal Health, Henry Schein, DocMorris, Merck, Siemens Healthineers and Bayer Aktiengesellschaft.
How can I get DocCheck stock analyzed?
Clicking "Analyze stock" lets five strategies assess DocCheck against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.